Details for New Drug Application (NDA): 210658
✉ Email this page to a colleague
The generic ingredient in IMATINIB MESYLATE is imatinib mesylate. There are thirty-four drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the imatinib mesylate profile page.
Summary for 210658
Tradename: | IMATINIB MESYLATE |
Applicant: | Zydus Pharms |
Ingredient: | imatinib mesylate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 210658
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 210658 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-244 | 68382-244-05 | 500 TABLET, FILM COATED in 1 BOTTLE (68382-244-05) |
IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 210658 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-244 | 68382-244-16 | 90 TABLET, FILM COATED in 1 BOTTLE (68382-244-16) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Apr 8, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 400MG BASE | ||||
Approval Date: | Apr 8, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription